Investor
Juvenescence
Juvenescence is a life sciences firm developing therapies to modify ageing and increase healthy human lifespan through drug development and AI-enabled R&D.
Stage
Seed
Sectors
2 sectors
Cheque
Not confirmed
Invests in
Not confirmed
Sectors
Digital HealthConsumer Wellbeing
About
Juvenescence is a clinical-stage drug development company dedicated to extending healthy lifespan through medicines. The firm targets core pathways of ageing to prevent age-related diseases. The team leverages cutting-edge data science approaches to unlock successful drugs in the longevity space. They also invest as a founder investor in biotechnology companies to advance therapeutics for chronic conditions.
Portfolio · 4 · tap a company to read about it
